Related Experiment Video
Updated: Jun 17, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
A Generative AI Framework for Pharmacokinetic Clinical Study Report Authoring
John Samuelsson1, Samuel Blakeman1, Ezra Alexander1
1Pfizer Inc., New York City, New York, USA.
Abstract:
Clinical Study Reports (CSRs) constitute the final consolidation of findings from clinical studies and routinely include Pharmacokinetic (PK) results. To assist with PK results authoring, we developed a generative Artificial Intelligence (AI) based method that employs a hierarchical, chained large language model (LLM) framework with in-context learning to draft PK results directly from study Tables, Listings, and Figures (TLFs), with optional human input. Unlike traditional fine-tuning approaches, our method does not require large datasets or extensive compute, while producing outputs closely aligned with established CSR structure, tone, and analytical conventions using fewer than a dozen example reports. To assess performance, AI-generated reports and manually expert-written CSRs were evaluated in two blinded review sessions by clinical pharmacologists and pharmacometricians, focusing on relative bioavailability (rBA) and drug-drug interaction (DDI) studies. The AI-generated reports achieved an average reporting quality score of ~90% relative to the manually written CSRs. Together, these results demonstrate a practical, scalable solution for assisting PK report authoring in clinical studies, potentially reducing authoring time while maintaining high-quality standards.
Related Concept Videos
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis of Population Pharmacokinetic Data
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
